Prevention of Cardiac Allograft Arteriosclerosis by Protein Tyrosine Kinase Inhibitor Selective for Platelet-Derived Growth Factor Receptor
- 4 May 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (17) , 2295-2301
- https://doi.org/10.1161/01.cir.99.17.2295
Abstract
Background—Increased immunoreactivity of platelet-derived growth factor (PDGF)-AA, -Rα, and -Rβ in intimal cells correlates with the development of cardiac allograft arteriosclerosis, a condition f...Keywords
This publication has 20 references indexed in Scilit:
- Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor.Journal of Clinical Investigation, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- PDGF ligand and receptor gene expression during repair of arterial injury.The Journal of cell biology, 1990
- Localization of PDGF-B Protein in Macrophages in All Phases of AtherogenesisScience, 1990
- Platelet-derived growth factor: Three isoforms and two receptor typesTrends in Genetics, 1989
- Signal Transduction by the Platelet-Derived Growth Factor ReceptorScience, 1989
- Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AAScience, 1989
- Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human AtheromaNew England Journal of Medicine, 1988
- The biology of platelet-derived growth factorCell, 1986
- Ribonucleic acid isolated by cesium chloride centrifugationBiochemistry, 1974